Transforming Medicine Together
Paul Chinn leads a Biogen Idec team in groundbreaking cancer research. Read how Paul’s work has helped Rick.
Eastern Cooperative Oncology Group (ECOG) Phase III Trial Of Rituxan Maintenance Therapy In Indolent Non-Hodgkin’s Lymphoma Reaches Pre-Specified Efficacy Endpoint Early
Biogen Idec invests in its employees. We offer challenges, learning and innovation along with a comprehensive compensation and benefits program. We invite you to join us.